Patents by Inventor Erin Anne KIMBREL

Erin Anne KIMBREL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20220160778
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: November 2, 2021
    Publication date: May 26, 2022
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20210182552
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: September 16, 2020
    Publication date: June 17, 2021
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20190175656
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: September 7, 2018
    Publication date: June 13, 2019
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20170252374
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and method sof treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: March 23, 2017
    Publication date: September 7, 2017
    Applicant: Astellas Institute for Regenerative Medicine
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20160038543
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: October 1, 2014
    Publication date: February 11, 2016
    Applicant: Advanced Cell Technology, Inc.
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20150272994
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: February 23, 2015
    Publication date: October 1, 2015
    Applicant: Ocata Therapeutics, Inc.
    Inventors: Erin Anne Kimbrel, Robert P. Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • Mesenchymal stromal cells and uses related thereto
    Patent number: 8962321
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 24, 2015
    Assignee: Ocata Therapeutics, Inc.
    Inventors: Erin Anne Kimbrel, Robert Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • Mesenchymal stromal cells and uses related thereto
    Patent number: 8961956
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: February 24, 2015
    Assignee: Ocata Therapeutics, Inc.
    Inventors: Erin Anne Kimbrel, Robert Lanza, Jianlin Chu, Nicholas Arthur Kouris
  • MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO
    Publication number: 20140072537
    Abstract: The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
    Type: Application
    Filed: May 30, 2013
    Publication date: March 13, 2014
    Inventors: Erin Anne KIMBREL, Robert LANZA, Jianlin CHU, Nicholas Arthur KOURIS